Stock Events

Stock Events

Clinuvel Pharmaceuticals (UR9.F) Q3 2024 Earnings

28AugConfirmed

Q1 2023

Q3 2023

Q1 2024

Q3 2024

0.13

0.18

0.24

0.3

Details

Expected EPS

0.2639687824818

Actual EPS

0.295994957544

Surprise EPS

0.03

Surprise Percent

+12.13%

Description

Clinuvel Pharmaceuticals (UR9.F) has reported earnings of 0.295994957544 per share for Q3 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.